Study of real-World Effectiveness and Tolerability in Indian Patients Receiving Etoricoxib Fast-Disintegrating Tablets for Acute Pain (SWIFT): A Prospective Multicentre Observational Evaluation
Fortune Journal of Health Sciences · 2026 · 9 (3)
DOI: 10.26502/fjhs.420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fortune Journal of Health Sciences, 2026. Verfasst von Girish Motwani und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Motwani, G., Swain, B. K., Ameta, C. K., Srivastava, A., Muchhala, S., & Natarajan, V. (2026). Study of real-World Effectiveness and Tolerability in Indian Patients Receiving Etoricoxib Fast-Disintegrating Tablets for Acute Pain (SWIFT): A Prospective Multicentre Observational Evaluation. Fortune Journal of Health Sciences, 9(3). https://doi.org/10.26502/fjhs.420
Vancouver
Motwani G, Swain BK, Ameta CK, Srivastava A, Muchhala S, Natarajan V. Study of real-World Effectiveness and Tolerability in Indian Patients Receiving Etoricoxib Fast-Disintegrating Tablets for Acute Pain (SWIFT): A Prospective Multicentre Observational Evaluation. Fortune Journal of Health Sciences. 2026;9(3). doi:10.26502/fjhs.420
BibTeX
@article{Motwani2026,
author = {Motwani, Girish and Swain, Braja Kishore and Ameta, Chandra Kant and Srivastava, Ashish and Muchhala, Sameer and Natarajan, Vidhya},
title = {Study of real-World Effectiveness and Tolerability in Indian Patients Receiving Etoricoxib Fast-Disintegrating Tablets for Acute Pain (SWIFT): A Prospective Multicentre Observational Evaluation},
journal = {Fortune Journal of Health Sciences},
year = {2026},
volume = {9},
number = {3},
doi = {10.26502/fjhs.420}
}
EUVIMED